Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.42 USD | +0.36% | +5.06% | -21.23% |
Apr. 17 | Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating | MT |
Apr. 15 | Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.23% | 771M | |
-19.04% | 26.87B | |
+20.88% | 11.17B | |
+1.03% | 4.97B | |
+2.51% | 503M | |
-10.80% | 442M | |
+0.19% | 308M | |
-23.60% | 227M | |
0.00% | 203M | |
-39.65% | 199M |
- Stock Market
- Equities
- WKME Stock
- News WalkMe Ltd.
- KeyBanc Initiates WalkMe at Sector Weight, Sees Revenue Reacceleration Taking Time, Margin Improvement 'Harder to Come by'